12
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Oral S-adenosyl-L-methionine (SAMe) administration enhances bile salt conjugation with taurine in patients with liver cirrhosis

, , , &
Pages 459-464 | Received 29 Nov 1993, Accepted 26 Apr 1994, Published online: 08 Jul 2009
 

Abstract

We investigated whether the oral administration of SAMe influences the hepatic availability of sulphur amino acids and the extent of bile salt amidation with taurine in liver cirrhosis. Ten patients with cirrhosis (eight Child-Pugh A and 2 B, aged 48-65 years), were studied before and 2 months after oral SAMe administration (800 mg per day). Bile was obtained using a string-test device (Entero-test), after gall-bladder contraction with caerulein. No significant changes were found in the per cent composition of biliary amino acids, except for an increase in glutamic -acid (from 3.7 ± 0.6% before to 6.1 ± 1.1% after SAMe, p = 0.003) and taurine from 2.2 ± 2.3% (range 0.4-6.8) to 7.2 ± 9.2% (range 0.5-28.1), (NS). HPLC analysis showed a trend towards increased per cent tauroconjugation of all individual bile salts, with a significant rise in tauro-chenodeoxycholic acid (from 15.0 ± 9.4% to 25.3 ± 9.7%, p = 0.05) and a drop in glycocholic acid (from 39.1 ± 15.3% to 25.3 ± 9.8%, p = 0.05). These data suggest that in the cirrhotic liver exogenous SAMe is partially metabolized to taurine, which is used for bile salt amidation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.